CAR-T therapy works by taking a patient's immune cells, modifying them in a lab to better recognise cancer, and then infusing ...

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...

A new CAR-T cell therapy has shown promising early results against glioblastoma, a highly aggressive brain cancer. In a phase ...

A new cancer drug, still in the experimental phase, showed near-complete tumour shrinkage in the brain.

CAR-T therapy has transformed treatment for some blood cancers, with seven FDA-approved products and strong clinical responses in hematologic malignancies.

Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...

Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric ...

A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.

Glioblastoma is one of the most aggressive brain tumors, with poor survival rates and limited treatment options. Standard ...

A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected ...

Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana is offering a CAR-T cell-based immunotherapy, which genetically ...